Balsamo, Jovina P.

HRN: 28-90-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2026
CO-AMOXICLAV 625MG (TAB)
05/08/2026
05/15/2026
PO
625 Mg/tab
BID
S/P CS
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines